Response of metastatic breast cancer to trastuzumab?

被引：18
|
作者：
Barnes, DM [1 ]
Miles, DW
机构：
[1] Guys Hosp, Imperial Canc Res Fund, Breast Pathol Lab, London SE1 9RT, England
[2] Guys Hosp, Imperial Canc Res Fund, Breast Biol Grp, London SE1 9RT, England
来源：
LANCET | 2000年 / 355卷 / 9199期
关键词：
D O I：
10.1016/S0140-6736(99)00430-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：160 / 161
页数：2
相关论文
共 50 条
  • [41] Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
    Bardia, Aditya
    Hu, X.
    Dent, Rebecca
    Yonemori, Kan
    Barrios, Carlos H.
    O'Shaughnessy, Joyce A.
    Wildiers, Hans
    Pierga, Jean-Yves
    Zhang, Qingyuan
    Saura, Cristina
    Biganzoli, Laura
    Sohn, Joohyuk
    Im, Seock-Ah
    Levy, Christelle
    Jacot, William
    Begbie, Natasha
    Ke, Jun
    Patel, Gargi
    Curigliano, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (22): : 2110 - 2122
  • [42] Recent advances in the treatment of metastatic breast cancer by adding trastuzumab
    Marty, M
    EJC SUPPLEMENTS, 2006, 4 (04): : 9 - 13
  • [43] Clinical role of trastuzumab in metastatic breast cancer: experience of a center
    S Menjón-Beltrán
    R Olivencia
    E Gonzalez
    Breast Cancer Research, 9
  • [44] Trastuzumab in metastatic HER2+ breast cancer: cardiotoxicity
    Reactions Weekly, 2020, 1794 (1) : 12 - 12
  • [45] ASSESSMENT OF SAFETY PROFILE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTS
    Rana, C.
    Mann, K.
    Wadhwa, A.
    VALUE IN HEALTH, 2011, 14 (03) : A158 - A158
  • [46] PTEN loss is not associated with trastuzumab resistance in metastatic breast cancer
    Kocar, Muharrem
    Bozkurtlar, Emine
    Telli, Ferhat
    Turhal, Nazim Serdar
    Kaya, Handan
    Kocar, Hande
    Yumuk, Fulden
    JOURNAL OF BUON, 2014, 19 (04): : 900 - 905
  • [47] Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer
    Ugrakli, Muzaffer
    Araz, Murat
    Demirkiran, Aykut
    celik, Ahmet Faruk
    Karakurt Eryilmaz, Melek
    Karaagac, Mustafa
    Artac, Mehmet
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (03) : 740 - 745
  • [48] Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients
    Lunardi, G
    Vannozzi, MO
    Bighin, C
    Del Mastro, L
    Stevani, I
    Schettini, G
    Venturini, M
    ANNALS OF ONCOLOGY, 2003, 14 (08) : 1222 - 1226
  • [49] Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer
    Hortobagyi, GN
    SEMINARS IN ONCOLOGY, 2001, 28 (06) : 43 - 47
  • [50] Therapeutic effects of trastuzumab combined with anthracyclines in metastatic breast cancer
    Li, Tao
    Ma, Xiaoming
    Huang, Anwen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 10039 - 10047
12345